Allscripts Healthcare Solutions (MDRX) has now come up with a real-time and point of care solution Population Health Analytics that will help reduce high cost of chronic disease management and check readmissions.
MDRX will demonstrate the Analytics solution at The Allscripts Client Experience (ACE) at Chicago’s McCormick Place from Aug 21 to 23. It provides analytics for costly and high priority chronic maladies such as Diabetes, Heart Disease, Coronary Artery Disease and Asthma.
According to President and Chief Executive Officer of Allscripts, Paul M. Black, its Population Health Analytics indicates a move from individual patient care to population health care. The data generated by the Analytics help physicians identify target populations, measure performance and outcomes, and inform and guide prompt clinical intervention for chronic ailments and readmission risks.
Allscripts Healthcare Solutions is a leading clinical software and information solutions provider for physicians. Its products are used widely across the U.S. and Canada. Currently, the company serves approximately 180,000 physician practices, 1,500 hospitals, and 10,000 post acute care facilities.
Recently, Portland-Maine based Mercy Health System revealed that it has chosen Allscripts Healthcare Solutions’ Revenue Cycle Management (RCM) Services in order to improve their reimbursement processes at a lower cost and reduced implementation time. RCM Services provide a complete revenue management solution from front office to back office processing and patient collections.
A few days back, N.C.-based Appalachian Regional Healthcare System also announced that it has implemented Allscripts Healthcare Solutions’ Electronic Health Record (EHR) system known as Sunrise Clinical Manager (SCM). SCM will help Appalachian maintain integrated patient records with the same graphical interface across the health system.
Allscripts Healthcare Solutions posted a significant fall in adjusted earnings to $2.2 million or a penny per share in the second quarter of 2013 from $23.1 million or 13 cents in the comparable quarter of 2012. With this, earnings also missed the Zacks Consensus Estimate of 7 cents for the quarter.
Revenues in the quarter ebbed 6.8% to $344.8 million, again missing the Zacks Consensus Estimate of $358 million. The decrease can be attributable to lower revenues generated from all the operating segments.
While we avoid MDRX being a Zacks Rank #4 (Sell) stock, other scrips that are performing well in the medical products industry include Hanger, Inc. (HGR) and Alere Inc. (ALR), both with a Zacks Rank #1 (Strong Buy), and in the medical information systems industry such as Medidata Solutions, Inc. (MDSO) with a Zacks Rank #2 (Buy).
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment